Economic Burden of Treatment-Resistant Depression among Adults with Chronic Non-Cancer Pain Conditions and Major Depressive Disorder in the US | Zendy

Drishti Shah | Zendy; Lindsay Allen | Zendy; Wanhong Zheng | Zendy; Suresh Madhavan | Zendy; Wenhui Wei | Zendy; Traci J. LeMasters | Zendy; Usha Sambamoorthi | Zendy

Open Access

Economic Burden of Treatment-Resistant Depression among Adults with Chronic Non-Cancer Pain Conditions and Major Depressive Disorder in the US

Author(s) -

Drishti Shah,

Lindsay Allen,

Wanhong Zheng,

Suresh Madhavan,

Wenhui Wei,

Traci J. LeMasters,

Usha Sambamoorthi

Publication year - 2021

Publication title -

pharmacoeconomics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.809

H-Index - 100

eISSN - 1179-2027

pISSN - 1170-7690

DOI - 10.1007/s40273-021-01029-2

Subject(s) - treatment resistant depression , major depressive disorder , depression (economics) , medicine , cohort , incidence (geometry) , psychiatry , mood , optics , economics , macroeconomics , physics

Major depressive disorder (MDD) and chronic non-cancer pain conditions (CNPC) often co-occur and exacerbate one another. Treatment-resistant depression (TRD) in adults with CNPC can amplify the economic burden. This study examined the impact of TRD on direct total and MDD-related healthcare resource utilization (HRU) and costs among commercially insured patients with CNPC and MDD in the US.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research